Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
Blood Pressure Lowering
100%
Body Mass Index
100%
Calcium Antagonists
33%
Cardiovascular Effects
16%
Cardiovascular Mortality
16%
Cardiovascular Risk
100%
Categorical Variables
16%
Coronary Artery Disease
16%
Diuretics
33%
Drug Choice
16%
Drug Class
16%
Hazard Ratio
16%
Heart Failure Death
16%
High Body Mass Index
16%
Individual Patient Data
16%
Major Adverse Cardiovascular Events
33%
Meta-analysis
100%
Meta-analysis Regression
16%
Meta-regression
33%
Normal Weight
16%
Obese Men
16%
Randomized Trial
100%
Risk Reduction
16%
Systolic Blood Pressure
16%
Three-body
16%
Trialists
16%
Medicine and Dentistry
ACE Inhibitor
14%
Apoplexy
14%
Blood Pressure
100%
Body Mass Index
100%
Calcium Antagonist
28%
Cardiovascular Risk
100%
Cardiovascular System
57%
Diuretic Agent
28%
Hazard Ratio
14%
Heart Failure
14%
Ischemic Heart Disease
14%
Meta-Analysis
100%
Meta-Regression
28%
Patient-Data
14%
Risk Reduction
14%
Systolic Blood Pressure
14%
Nursing and Health Professions
Blood Pressure
100%
Body Mass
100%
Calcium Antagonist
28%
Cardiovascular Risk
100%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Diuretic Agent
28%
Hazard Ratio
14%
Heart Failure
14%
Ischemic Heart Disease
14%
Meta Analysis
100%
Patient Coding
14%
Systolic Blood Pressure
14%
Agricultural and Biological Sciences
ACE Inhibitor
14%
Blood Pressure
100%
Body Mass Index
100%
Cardiovascular System
100%
Diuretic
28%
Meta-Analysis
100%
Risk Reduction
14%
Systolic Blood Pressure
14%
Pharmacology, Toxicology and Pharmaceutical Science
Calcium Antagonist
100%
Cardiovascular Risk
100%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Diuretic Agent
100%
Heart Failure
50%
Ischemic Heart Disease
50%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
14%
Blood Pressure
100%
Body Mass
100%
Enzyme Inhibitor
14%
Patient Coding
14%
Risk Reduction
14%
Systolic Blood Pressure
14%